About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
BNF Category
1: Gastro-intestinal system
2: Cardiovascular system
3: Respiratory system
4: Central nervous system
5: Infections
6: Endocrine system
7: Obstetrics, gynaecology, and urinary-tract disorders
8: Malignant disease and immunosuppression
9: Nutrition and blood
10: Musculoskeletal and joint diseases
11: Eye
12: Ear, nose, and oropharynx
13: Skin
14: Immunological products and vaccines
15: Anaesthesia
Appendix 7
Appendix 8 Wound management products and elasticated garments
Non-BNF miscellaneous
Emergency treatment of poisoning
3.1 Bronchodilators
3.2 Corticosteroids
3.3 Cromoglicate and related therapy and leukotriene receptor antagonists
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.5 Respiratory stimulants and pulmonary surfactants
3.6 Oxygen
3.7 Mucolytics
3.8 Aromatic inhalations
3.9 Cough preparations
3.10 Systemic nasal decongestants
30 library items
in 3.7 Mucolytics
Filter results by:
Date Published
2012 (0)
2011 (6)
2010 (3)
2009 (3)
2008 (4)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
3: Respiratory system (
remove
)
,
3.7 Mucolytics (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 30
Result page:
Previous
|
1
2
3
|
Next
1.
Horizon scanning: Licensing application for ivacaftor (KalydecoTM), the first potential medicine to target underlying cause of cystic fibrosis, accepted by FDA and EMA
Source:
BioSpace
,
Date published:
16/12/2011
Category:
3.7 Mucolytics
|
Cystic fibrosis
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Food &Drug Administration (FDA)
|
New drugs
NeLM
Area:
News
Link
Link to NeLM report of RCT
2.
RCT: Intrapleural tissue plasminogen activator and DNase in pleural infection
Source:
N Engl J Med
,
Date published:
11/08/2011
Category:
2.10.2 Fibrinolytic drugs
|
3.7 Mucolytics
|
Respiratory Medicine
NeLM
Area:
News
Link- to study- full text access may be restricted to subscribers
3.
Reports suggest mannitol may receive negative opinion from CHMP for use in cystic fibrosis
Source:
BioSpace
,
Date published:
27/05/2011
Category:
3.7 Mucolytics
|
Cystic fibrosis
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
New drugs
NeLM
Area:
News
BioSpace story
4.
Timing of dornase alfa inhalation for cystic fibrosis
Source:
Cochrane Library
,
Date published:
20/05/2011
Category:
3.7 Mucolytics
|
Cystic fibrosis
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link to Abstract
5.
3.7 Mucolytics
Source:
St. George's Healthcare NHS Trust
,
Date published:
23/03/2011
Category:
3.7 Mucolytics
NeLM
Area:
Formularies
>
Trusts
>
St George's Healthcare NHS Trust Formulary
>
Products
>
Approved Prescribing List
>
3: Respiratory system
6.
3.7 Mucolytics
Source:
Guy's and St. Thomas' NHS Foundation Trust
,
Date published:
01/01/2011
Category:
3.7 Mucolytics
NeLM
Area:
Formularies
>
Trusts
>
Guy's, King's, Lewisham & St.Thomas' Hospitals Joint Formulary
>
Products
>
Approved Prescribing List
>
3: Respiratory system
7.
3.7 Mucolytics
Source:
Buckinghamshire Formulary
,
Date published:
13/09/2010
Category:
3.7 Mucolytics
NeLM
Area:
Formularies
>
Trusts
>
Buckinghamshire Formulary
>
Products
>
Formulary
>
Formulary
>
3: Respiratory system
8.
3.7 Mucolytics
Source:
Chelsea and Westminster Hospital Formulary
,
Date published:
07/07/2010
Category:
3.7 Mucolytics
NeLM
Area:
Formularies
>
Trusts
>
Chelsea & Westminster Hospital Formulary
>
Products
>
Approved Prescribing List
>
3: Respiratory system
9.
Annual Evidence Update on Cystic Fibrosis: 10-14 May 2010
Source:
NHS Evidence
,
Date published:
10/05/2010
Category:
3.7 Mucolytics
|
Clinical guidelines
|
Cystic fibrosis
NeLM
Area:
News
Link to NHS Evidence – respiratory
Link to NHS Evidence – genetic conditions
10.
NHS Evidence Annual Evidence Update on Cystic Fibrosis: 11-15 May 2009
Source:
NHS Evidence
,
Date published:
08/05/2009
Category:
3.7 Mucolytics
|
5.1 Antibacterial drugs
|
Cystic fibrosis
|
Information provision
NeLM
Area:
News
Link
Results 1 - 10 of 30
Result page:
Previous
|
1
2
3
|
Next